ScienceAlert on MSN
Parkinson's Discovery Suggests We May Have an FDA-Approved Treatment Already
Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material ...
Australian-founded medical technology company SYMBYX today announced compelling results from a 72-week randomized controlled ...
Data from Phase IIb PADOVA study and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease Prasinezumab is a potential first-in-class ...
Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
Mission Therapeutics, a clinical-stage biotechnology company, has raised $13.3m to advance the clinical development of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback